A New Scoring System to Predict Poor Clinical Outcomes in Acute Nonvariceal Upper Gastrointestinal Bleeding Patients with High-Risk Stigmata

Table 2

Univariate and multivariate analysis between rebleeding case and no rebleeding case.

	Rebleeding case ()	No rebleeding case ()	value	value
Age (>60), number (%)	17 (44.7%)	66 (38.6%)	0.485
Sex (male), number (%)	30 (78.9%)	143 (83.6%)	0.491
HR (>100 beats/min), number (%)	12 (31.6%)	27 (15.8%)	0.027
SBP (<90 mmHg), number (%)	5 (13.2%)	6 (3.5%)	0.025	0.016
Alcohol (yes), number (%)	9 (23.7%)	31 (18.1%)	0.433
Smoke (yes), number (%)	14 (36.8%)	50 (29.2%)	0.359
UGIB history (yes), number (%)	8 (21.1%)	40 (23.4%)	0.757
Multiple therapies, number (%)	3 (7.9%)	34 (19.9%)	0.092	0.015
HR/SBP, mean (SD)	0.89 (0.38)	0.73 (0.21)	0.023
HB, mean (SD), g/L	86.82 (26.94)	105.25 (26.47)	0.001	0.002
BUN, mean (SD), mmol/L	13.53 (6.92)	10.55 (5.77)	0.004	0.115
Creatinine, mean (SD), μmol/L	103.55 (46.49)	82.08 (49.39)	0.001	0.004
Glucose, mean (SD), mmol/L	8.09 (3.44)	7.93 (3.97)	0.188
ALT, mean (SD), U/L	41.13 (70.54)	28.71 (22.28)	0.268
AST, mean (SD), U/L	42.37 (84.1)	24.73 (26.97)	0.693

HR: heart rate; SBP: systolic blood pressure; HB: hemoglobin; BUN: blood urea nitrogen; AST: aspartate transaminase; ALT: alanine aminotransferase; multiple therapies was defined as submucosal epinephrine injection plus thermal or mechanical hemostasis.